Accumulating evidence in human cancer cell lines has now confirmed that LGR5 promotes the growth and survival of ovarian carcinoma (12), basal cell carcinoma (13), colorectal and gastric carcinoma, esophageal adenocarcinoma (9,10,14,15) and liver carcinoma (16). This evidence concerns the gene LGR5 and cancer.